18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy

Trial Profile

18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Flortaucipir-F-18 (Primary) ; Florbetapir F 18
  • Indications Encephalopathy
  • Focus Diagnostic use
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 19 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 19 Dec 2014 Planned End Date changed from 1 Dec 2014 to 1 Jul 2015, according to the ClinicalTrials.gov record.
    • 19 Dec 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Jul 2015, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top